Department of Health and Social Care
Government invests in global partnership to treat gonorrhoea
The £3.5 million investment will help develop new treatments for gonorrhoea and make them available to low- and middle-income countries.
The investment is part of a continued partnership with the Global Antibiotic Research and Development Partnership (GARDP), a not-for-profit research and development organisation co-founded by the World Health Organization and the Drugs for Neglected Disease initiative in 2016.
- enable global access to treatment, including in low- and middle-income countries where the burden of antimicrobial resistance (AMR) is greatest
- fund GARDP’s development of oral antibiotic zoliflodacin, which is now in the last stage of clinical trials before reaching the market
Zoliflodacin is one of the few antibiotics in development to specifically treat gonorrhoea and is significant as treatments for gonorrhoea are becoming less effective.
There have been cases of gonorrhoea developing resistance to recommended treatments, including in the UK.
Gonorrhoea is among the most common sexually-transmitted infections (STIs), with an estimated 87 million new cases globally every year.
The STI can have severe consequences on public health and, when left untreated, serious consequences for reproductive health as well as increased risk of transmission of HIV and other STIs.
Women, and marginalised and vulnerable groups are disproportionately affected.
Gonorrhoea has been identified as posing a significant threat to global health by the World Health Organization (WHO). There is now an urgent need for new treatment options, particularly for people in developing countries.
Addressing drug-resistant infections is critical to achieving the UN’s sustainable development goals, particularly the target for good health and wellbeing for all.
GARDP will now start pharmaceutical development activities for zoliflodacin, and will develop a new strategy for access and appropriate use in low- and middle-income countries that have a high number of cases of gonorrhoea.
Minister for Innovation, Nicola Blackwood, yesterday said:
The UK is a global leader in tackling antimicrobial resistance, a threat that is posing serious risks to health and the global economy, as well as killing hundreds of thousands of people around the world each year.
It is vital to fund new antibiotic research and development to tackle AMR and this innovative project will develop solutions to treat the global rise of gonorrhoea and improve the quality of people’s lives.
Dr Manica Balasegaram, Executive Director of GARDP, yesterday said:
We are excited to unveil our new strategy, 5 BY 25, outlining GARDP’s ambition to accelerate the development of 5 new treatments by 2025.
The recent initiation of the phase 3 trial of zoliflodacin is an important milestone towards bringing one of our 5 treatments a step closer to patients by 2025.
The global nature of the trial, across 4 continents, represents our commitment to ensuring this treatment is available to anyone in need, wherever they live.
Latest News from
Department of Health and Social Care
Cold weather alert issued by PHE18/11/2019 13:10:00
Public Health England (PHE) issues cold weather alert following the arrival of colder weather in some parts of England.
UK SMI S 7: gastroenteritis12/11/2019 10:10:10
Public Health England is seeking views on the UK Standards for Microbiology Investigations S 7, which apply to gastroenteritis.
New measures to secure MMR vaccine for private patients06/11/2019 10:10:10
New restrictions mean the MMR vaccine cannot be parallel exported from the UK, to protect stock for private patients and those not eligible for routine NHS jabs.
£26 million to help hospitals introduce digital prescriptions04/11/2019 10:25:00
25 trusts will receive a share of the funding to replace outdated paper systems, improving patient safety and reducing errors.
Approval for new trial to prevent Group B Strep in newborn babies04/11/2019 09:25:00
Ethical approval has been given for a £2.8 million trial to prevent Group B Strep being passed on to newborn babies.
165 new antibiotic resistant infections every day in England01/11/2019 10:10:10
The Keep Antibiotics Working campaign returns, urging people to always take their doctor's, pharmacist's or nurse’s advice on antibiotics.
100,000 more people to be given personal health budgets31/10/2019 14:20:00
A change in law means people who use wheelchairs or need mental health support will have greater choice and control in managing their own health and care.
78 NHS trusts to receive new cancer screening machines31/10/2019 10:10:10
The trusts will receive funding for new machines that will improve patient experience and lead to earlier diagnosis.